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Sequence analysis of the genomes of the Leporipoxviruses myxoma virus and Shope fibroma virus (SFV) led to the 
discovery of open reading frames homologous to the vaccinia H1 L gene encoding a soluble protein phosphatase with dual 
tyrosine/aerine specificity. These viral phosphatase genes were subsequently localized to the myxoma BamHl-I fragment 
and the SFV BamHI-M fragment, and the resulting encoded proteins were designated IlL and M1L, respectively. The 
localization and orientation of the myxoma I1L and SFV M1 L open reading frames within the well conserved central core 
of the viral genomes closely mirror that of the Orthopoxviruses vaccinia virus and variola virus. The myxoma i lL and SFV 
M1L phosphatases each contain the conserved tyrosine phosphatase signature sequence motif, (i/V)HCXAGXXR(S/T)G, 
including the active site cysteine, found previously to be essential for phosphotyrosine dephosphorylation. The vaccinia 
H1L phosphatase was originally shown to have the ability to dephosphorylate phosphotyrosyl and phosphoseryl residues 
in vitro. To assess whether this is a common feature of poxvirus phosphatases, myxoma IlL was expressed as a GST- 
fusion protein, purified, and shown to dephosphorylate substrates containing tyrosine and serine phosphorylated residues, 
in a similar fashion to vaccinia H1L. A myxoma IlL variant, in which the active site cysteine t10 was mutated to serine, 
was expressed in a parallel fashion to the wild-type IlL protein and found to be completely deficient in its ability to 
dephosphorylate both phosphotyrosine and phosphoserine amino acids. In an attempt o ascertain the biological requirement 
for the myxoma I1L phosphatase, we constructed a recombinant myxoma virus containing a disrupted IlL open reading 
frame. This IlL mutant virus was able to successfully propagate in tissue culture only in the presence of a wild-type 
complementing ene, and pure virus clones containing only the disrupted allele were not viable. Thus, we conclude that 
the myxoma I1L dual specificity phosphatase is an essential factor for virus viability. © 1995 Academic Press, Inc. 
INTRODUCTION 
Reversible phosphorylation of proteins is a well estab- 
lished mechanism in controlling eukaryotic intracellular 
events (Fischer and Krebs, 1989). Overall cellular phos- 
phoprotein levels are controlled by a dynamic balance 
between protein kinases and protein phosphatases 
(Hunter and Cooper, 1985; Hunter, 1987; Cohen, 1989; 
Charbonneau and Tonks, 1992). The vast majority of ki- 
nases and phosphatases act on serine and threonine 
residues, and until 1980 these two residues were the 
only identified naturally occurring phosphoamino acids 
(Hunter and Sefton, 1980). Studies with Rous sarcoma 
virus drew attention to tyrosine phosphorylation when it 
was shown that v-src, the virus gene product responsible 
for transformation, encoded a cell-derived protein tyro- 
sine kinase (Hunter and Sefton, 1980). Even though tyro- 
sine phosphorylation accounts for less than 1% of the 
total protein phosphoamino acid content in a normal cell, 
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tyrosyl phosphorylated proteins have been implicated as 
critical regulators of many important signal transduction 
cascades. Protein tyrosine phosphatases have recently 
been recognized as important counterparts to protein 
tyrosine kinases in the regulation of tyrosine phosphory- 
lation of cellular proteins (Lau et aL, 1989; Fischer et al., 
1991; Charbonneau and Tonks, 1992; Lau and Baylink, 
1993; Walton and Dixon, 1993). Tyrosine phosphatases 
are as structurally diverse and complex as their cognate 
kinases and can be classified into two major groups= 
transmembrane or receptor-like and cytosolic or nonre- 
ceptor:like. Both classes of tyrosine phosphatases con- 
tain one or two homologous catalytic domains where the 
active site cysteinyl residue is located within a conserved 
sequence motif (Guan and Dixon, 1991). Thus, both tyro- 
sine kinases and phosphatases coordinate in the regula- 
tion of such diverse activities as proliferation, differentia- 
tion, and transformation (Lau and Baylink, 1993, and ref- 
erences therein). 
The ability to rapidly alter cellular function is also one 
attribute o f  poxviruses. Poxviruses are large, double- 
stranded DNA viruses which replicate in the cytoplasm 
of host cells (Moss, 1990). Due to their cytoplasmic local- 
ization of replication, poxviruses encode most of the en- 
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zymes required for virus replication and transcription. 
Among the various poxviral-encoded enzymes are nu- 
merous regulatory enzymes, such as protein kinases 
(Traktman eta/., 1989; Howard and Smith, 1989; Massung 
eta/., 1992, 1994) and protein phosphatases (Guan eta/., 
1991a; Massung et al., 1994). The first poxviral tyrosine 
phosphatase to be characterized was a cytosolic phos- 
phatase encoded bythe vaccinia virus H1L open reading 
frame, often referred to as VH1 (Guan et al., 1991a). Un- 
like all previously characterized tyrosine phosphatases 
which contain strict specificity for phosphotyrosyl resi- 
dues, H1L was shown to dephosphorylate both phos- 
phorylated tyrosyl and seryl residues in vitro. Subse- 
quently, other phosphatases with similar dual specificity 
have been characterized from other systems (Gautier et 
al., 1991; Hakes etaL, 1993; Noguchi eta/., 1993; Kwak 
eta/., 1994; Hannon eta/., 1994). 
Poxviruses encode a plethora of proteins which coun- 
teract host defense mechanisms, including such diverse 
targets as complement, growth factors, cytokines, MHO- 
restricted antigen presentation, and regulation of both B 
cell and T cell activation (reviewed in Turner and Moyer, 
1990; Buller and Palumbo, 1991; Smith, 1994; McFadden 
and Graham, 1994). It is conceivable that a poxvirus- 
encoded phosphatase could perturb a variety of func- 
tions, ranging from the replication of the viral genome to 
the disruption of cellular signaling pathways critical for 
the host immune response. Here, we report the identifi- 
cation of a cytosolic tyrosine phosphatase expressed 
by the Leporipoxviruses Sbope fibroma virus (SFV) and 
myxoma virus, the latter of which is best known for its 
ability to cause lethal myxomatosis in the European rab- 
bit (Fenner and Ratcliffe, 1965; McFadden, 1988, 1994). 
We have investigated the properties of the myxoma tyro- 
sine phosphatase, including genomic localization, ex- 
pression profile, substrate specificity, and the require- 
ment of phosphatase for virus viability in cultured cells. 
MATERIALS AND METHODS 
Viruses and cells 
Myxoma virus (strain Lausanne) and Shope fibroma 
virus (SFV, strain Kasza) have been previously described 
(Block et al., 1985), as has vMyxlac, a myxoma virus 
derivative which contains the Escherichia coil lacZ gene 
inserted at an innocuous site between the virus growth 
factor and M9 genes (Opgenorth et al., 1992). Viruses 
were propagated in BGMK cells grown in Dulbecco's 
minimal Eagle's medium (DMEM) supplemented with 
10% newborn calf serum (Gibco). LSTRA cells (provided 
by B. Sefton), used as a source for the tyrosine kinase 
p56/c~, were maintained in RPMI media containing 15% 
fetal calf serum and 50 ffM/3-mercaptoethanol. 
Cloning and sequencing of SFV and myxoma 
fragments 
The SFV BamHI-M fragment (Wills et al., 1983; Delange 
et aL, 1984) was identified by random sequencing to 
encode an open reading frame containing homology to 
the signature sequence motif of tyrosine phosphatases 
and was subcloned into Bluescript KS + (Stratagene) in 
both orientations. Nested deletions with exonuclease III 
and exonuclease VII (Henikoff, 1984) were constructed 
following cleavage by Sstl and BamHI (BRL). Sequencing 
data were compiled to obtain the entire 2.7-kb SFV 
BamHI-M fragment sequence. To amplify the SFV open 
reading frame, M1 L, that encoded the putative viral phos- 
phatase, polymerase chain reaction (PCR) was used. The 
5' primer incorporated a unique Xhol restriction site up- 
stream of the initiator codon (5'-GGCTCGAGAATGGAT- 
AAAAAAAG]-C-3'), and the 3' primer a BamHI site imme- 
diately downstream of the terminator codon (5'-CCGGAT- 
CC-FFTATGqTFCGlq-GATG-3'). The SFV M1L gene was 
amplified by 30 cycles at 94, 42, and 72 ° for 1 min each, 
using standard buffer conditions (50 mM KCI, 10 mM 
Tris, pH 8.3, 1.5 mM MgCI2, 0.01% gelatin, 50 #M dNTPs, 
and 1 unit Taq enzyme). 
To identify the myxoma phosphatase gene, genomic 
vMyxlac DNA was subjected to PCR analysis, using the 
SFV MIL 5' and 3' primers. PCR reaction conditions were 
as described above for the SFV M1L gene. The amplified 
537-bp myxoma fragment was radiolabeled to make 
probe by end-labeling with 1-4 polynucleotide kinase 
(BRL) and used in Southern blot analysis of myxoma 
DNA digested with BamHI to identify the genomic BamHI 
clone. The myxoma phosphatase homologue of SFV M1L 
mapped to the 6.4-kb BamHl-I fragment (Russell and Rob- 
bins, 1989), and following sequence analysis was desig- 
aated IlL. This genomic myxoma fragment was subse- 
quently cloned into Bluescript SK +, and sequencing was 
performed with the SFV M1L 5' and 3' primers plus four 
additional primers= P1 (5'-CTAGAGTACTTGAGTAGq-I-C- 
3'), P2 (5'-GATGCGCGTCACCGACTAC-3'), P3 (5'-CTA- 
GACATAAGATACGCC-3'), and P4 (5'-G-FFGTTAAACCC- 
CGCCCqq-C-3'). These six primers were used to obtain 
the entire myxoma IlL open reading frame, along with 
200 bp of both upstream and downstream sequence, in 
both orientations. All sequencing was performed on an 
ABI 373A DNA sequencer with Taq cycling to greater 
than fivefold redundancy. 
Northern analysis 
Subconfluent monolayers of BGMK ceils in 100-ram 
dishes were infected with vMyxlac virus at a multiplicity 
of infection of 30. RNA was extracted at various time 
points postinfection using guanidine thiocyanate, as pre- 
viously described (Macaulay eta/., 1987). Purified RNA 
(3 fig) was prepared in 3-(N-morpholino) propanesulfonic 
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acid (MOPS) buffer [20 mM MOPS, 5 mM NaOAc, 1 mM 
ethylenediaminetetraaceteic acid (EDTA)] containing 
50% deionized formamide and 20% formaldehyde. Sam- 
ples were incubated at 55 ° for 15 min, cooled on ice, 
and loaded onto a 1%.agarose gel containing 1X MOPS 
buffer, 2% formaldehyde, and 0.5 /~g/ml ethidium bro- 
mide. RNA was transferred to nitrocellulose via capillary 
action. For probe, random priming was performed using 
the myxoma IlL PCR product with [a-32P]dCTP (Amer- 
sham) and random primers (Boehringer Mannheim). Re- 
suits were visualized with autoradiography: 
Analysis of DNA and protein sequences 
To obtain the complete sequence of the SFV BamHI- 
M fragment, sequencing data were compiled using IG- 
Suite programs (Intelligenetics Corp. CA). Sequence 
analysis for constructing the entire myxoma IlL open 
reading frame was performed using GelAssemble (Ge- 
netics Computer Group, WI, hereafter denoted GCG). Se- 
quences of the entire SFV BamHI-M fragment and the 
myxoma IlL open reading frame have been submitted 
to GenBank (Accession Nos. L32180 and L31960, respec- 
tively). The PIR (Release 38) and GenBank (Release 79) 
databases were used to obtain additional poxviral phos- 
phatase sequences. DNA and peptide sequences were 
compared using Bestfit and PileUp (GCG). All computer 
analyses were performed at the Molecular Mechanisms 
in Growth Control Computer Facility, University of Al- 
berta. 
Plasmid constructions 
The glutathione S-transferase (GST) gene fusion sys- 
tem (Pharmacia) was used to express and partially purify 
vaccinia FILL, myxoma IlL, and a myxoma IlL mutant in 
which the catalytic cysteine residue, Cys110, is replaced 
by a serine (I 1 L-C110S). To create I1 L-C110S, the codon 
TGT for Cys110 was mutated to TCT, creating Ser110, 
using oligonucleotide-directed mutagenesis. In order to 
clone the three proteins in-frame into the BamHI site of 
pGEX-3X (Pharmacia), PCR was performed with vaccinia 
or myxoma DNAusing SFV M1L3' primer and a 5' primer 
(5'-G G C CG GATCCAAATG GATAAGAAAAG-3') which 
caused a single base change ofT-~ C in order to change 
an in-frame TAA codon, located directly upstream of the 
initiating ATG, to a CAA codon. The plasmids were desig- 
nated pGSTH1 L, pGSTI1 L, and pGSTI1Lm. 
To construct the myxoma IlL phosphatase disruption 
plasmid, two internal primers were made, each con- 
taining a complementary linker region with an internal 
Bglll restriction site. The primers were designated PIN 
(5' - GACCAAGATCTCGTACGA-Iq-CCCGATGTAGGAGC - 
3') and PIC (5'-GTACGAGATCTTGGTCGTATGGCCGGT- 
GTAAATC-3'). Two separate PCR reactions were per- 
formed, with SFV M1L 5' and PIN primers and SFV M1L 
3' and PIC primers. The 151-bp N-terminal and 190-bp C- 
terminal fragments were digested with Bglll (BRL), ligated 
together with T4 DNA ligase (BRL) and amplified using 
the SFV M1L 5' and 3' primers. The resulting 341-bp 
fragment was digested with Xhol and BamHI and cloned 
into Bluescript SK +, creating pai l  L. pai l  L was cleaved 
with Bglll, and ligated to a 3.15-kb Bglll cassette con- 
taining the E. colit3-galactosidase gene under the control 
of the vaccinia pl l  promoter (p11-LacZ) (Buller et al., 
1988). Two disruption plasmids were constructed con- 
taining both.orientations of the pl 1 -LacZ cassette, desig- 
nated pll L-LacZa and pll L-LacZb. 
Expression of vaccinia and myxoma phosphatases 
pGSTH1 L, pGSTI1 L, and pGSTI1Lm were transformed 
into E, coil BL21 (DE3)pLysS (Studier and Moffatt, 1986) 
for expression studies. Cultures were grown at 30 ° until 
OD60o = 1.5, at which time they were induced with 0.1 
mM IPTG and incubated a further 3 hr. Cells were har- 
vested by centrifugation, resuspended in phosphate-buf- 
fered saline containing 1 mg/ml lysozyme, incubated on 
ice for 45 min, and recentrifuged. MgCI2 to 8 mM was 
added to bacterial lysates which were treated with 10 
#g/ml DNAsel on ice for 1 hr. Inclusion bodies were 
removed by centrifugation at 10,000 g for 10 min at 4 ° . 
Bacterial supernatants were incubated with glutathione- 
Sepharose 4B (Pharmacia) and batch purified as per 
manufacturers protocol. Elution was performed with 10 
mM reduced glutathione in 50 mM Tris-HCI, pH 8.0. 
Free glutathione was removed by dialysis against 50 mM 
Tris-HCI (pH 8.0), 150 mM NaCI, and 0.1%/3-mercapto- 
ethanol. Dialyzed samples were stored at -20 ° in 50% 
glycerol. Protein concentrations were determined using 
BioRad Bradford assay. 
Phosphatase assays 
Hydrolysis of p-nitrophenyl phosphate (pNPP, Sigma), 
a chromogenic substrate for tyrosine-specific phospha- 
tases, was performed in 100 ffl of solution containing 25 
mM imidazole pH 7.2, 1 mM EDTA, 0.1 mM DFI-, 10 mM 
pNPP, and expressed GST-fusion enzyme at 30 ° for 30 
min. The reaction was stopped bythe addition of 5 #11 M 
sodium carbonate. Absorbance at 410 nm was measured 
using a Dynatech MR600 automated microplate spectre- 
photometer. 
Tyrosine phosphorylation of myelin basic protein 
(MBP) was performed overnight at 30 ° with p56/ok immu- 
noprecipitated from 5 x 10 ~ LSTRA cells and 100 /~Ci 
[T-32P]ATP (ION) in a total volume of 30 ffl in 10 mM 
piperazine-N,N'-bis[2-ethane-sulfonic a id] (PIPES), pH 
7.1/10 mM MnCI2. Phosphorylation of MBP by p56/ok has 
been shown to occur primarily on Tyr-67 (Wang et aL, 
1991). Tyrosine-phosphorylated MBP was recovered 
after trichloroacetic acid (TCA) precipitation in the pres- 
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ence of bovine serum albumin (BSA) carrier protein. The 
specific activity was calculated to be 1.2 X 106 cpm/#g 
input protein. Dephosphorylation assays were performed 
essentially as described (Streuli etaL, 1990). Briefly, 1 X 
104 cpm of tyrosine-phosphorylated MBP was mixed with 
increasing amoonts of GST-fusion enzyme in a total vol- 
ume of 50 #1 in 25 mM imidazole, pH 7.2/5 mM EDTA/ 
100 mM Dqq-. After 30 min at 30 ° the reactions were 
stopped with 0.85 ml of acidic charcoal mixture. After 10 
rain at room temperature the charcoal was pelleted by 
centrifugation and 600 #1 of the supematants quantitated 
for 32p release by Cerenkov counting. 
Serine phosphorylation of MBP and casein was per- 
formed by incubating 100 #g of protein with 300 #Ci [I/- 
32P]ATP and 10 units protein kinase A (Sigma) in 50 ffl 
solution containing 20 mM Tris, pH 7.4, 1 mM Dqq-, 100 
mM NaCI, and 12 mM MgCI2 at 30 ° overnight. Serine- 
phosphorylated MBP/casein was precipitated by the ad- 
dition of 0.1 ml of 5 mg/ml BSA and 0.5 ml of 20% TCA 
in 20 mM NaH2PO4, washed three times with 95% etha- 
nol, and resuspended in 100 ffl 0.2 M Tris, pH 8.0. The 
specific activities of MBP and casein were calculated 
to be 7.5 X 106 and 3.8 x 106 cpm/#g input protein, 
respectively. Assays were performed by incubating 1 X 
10 ~ cpm phospho-MBP/casein with increasing amounts 
of enzyme in 50-#1 reactions containing 25 mM imidazole, 
pH 7.2, 1 mM EDTA, and 0.1 mM D-I-I- for 30 rain at 
room temperature. Reactions were stopped with acidic 
charcoal and released 3Zp quantitated as outlined above. 
Construction of recombinant myxoma virus 
The recombinant phosphatase disruption virus was 
constructed from wild type myxoma virus (strain Lau- 
sanne) using the insertion vector plasmids pilL-LacZa 
and pllL-LacZb. Selection for insertion of the lacZ cas- 
sette using 5-bromo-4-chloro-3-indolyl-/g-D-galactopyran- 
oside (X-gal) was performed as previously outlined (Op- 
genorth eta/., 1992) with the exception that 1 #g of intact 
plasmid was utilized in the infection-transfection proce- 
dure. Individual blue plaques were harvested, and sub- 
jected to SDS-pronase treatment in which cells were 
incubated at 37 ° overnight in 10 mM Tris, pH 7.5, 10 
rnM EDTA, 0.5% SDS, and 300 #g pronaseE, followed by 
phenol/chloroform extraction and ethanol precipitation, 
in order to obtain viral E)NA for PCR analysis. All samples 
were PCR amplified with three separate primer sets= SFV 
M1L 5' and 3' primers to detect wild type myxoma IlL 
alleles, SFV M1L 5' primer and a lacZ 3' reverse primer 
(5'-AOCTTA-CCFATCAGOCG-3') to detect myxoma I1L 
disruption alleles, and 5' and 3 ' primers directed toward 
the myxorna T7 open reading frame as a DNA control. 
The lacZ 3' reverse primer lies 530 nucleotides from the 
termination codon within the coding region of lacZ and 
is designed to prime toward the 3' end of the lacZ gene. 
All PCR reactions were performed under conditions de- 
scribed above. 
RESULTS 
Genomic localization of putative SFV and myxoma 
phosphatase genes 
Exploratory sequencing of cloned Shope fibroma virus 
(SFV) BamHI fragments (Wills eta/., 1983) led to the fortu- 
itous discovery of a putative phosphatase sequence mo- 
tif in the BamHI-M fragment. Sequencing of the entire 
2.7-kb BamHI-M fragment revealed that the SFV M1L 
open reading frame was homologous to that of vaccinia 
H1L, which eneodes for a phosphatase (Guan et aL, 
1991a), often referred to as VH1. identification of the 
myxoma phosphatase gene was assisted by the high 
degree of homology between the SFV and myxoma virus 
genomes (McFadden, 1988). Using PCR primers directed 
against SFV M1L, a 0.5-kb amplified product was ob- 
tained using myxoma genomic DNA. Southern blot analy- 
sis using this amplified product as a probe localized the 
open reading frame within the BamHl-I fragment of the 
myxoma genome (Russell and Robbins, 1989) (data not 
shown). The myxoma phosphatase gene was sequenced 
from the cloned BamHl-I fragment of myxoma DNA and 
designated I1 L, since it is the first complete open reading 
frame within the BamHl-I fragment, and is oriented to- 
wards the left end. Figure 1 outlines the genomic localiza- 
tion of the myxoma and SFV phosphatase open reading 
frames. 
The SFV BamHI-M and myxoma BamHl-I fragments 
are both located approximately 64 kb from their respec- 
tive left terminal inverted repeats (TIRs), demonstrating 
similar genomic Iocalizations (Fig. 1). Previous studies 
suggested that the TIRs of SFV and myxoma virus were 
also quite similar (Upton et al., 1988, 1990). Comparison 
ofthe SFV M1L and myxoma I1L DNAsequences demon- 
strated an identity of 91.9% (Fig. 2) and the conserved 
location of portions of the two flanking open reading 
frames indicates a common evolutionary origin for SFV 
and myxoma virus (refer to Fig. 1). To the right of M1L 
of SFV and IlL of myxoma are M2R and 12R, respectively. 
M2R and 12R were identified as homologs to the similarly 
located H2R open reading frame of vaccinia virus 
(Goebel eta/., 1990), and 12R of variola virus (Massung 
eta/., 1994). To the left of M1L of SFV and I1L of myxoma 
are sequences which are homologous to the C-terminal 
portion of RP0147, the largest RNA polymerase subunit 
encoded by the J6R open reading frame of vaccinia virus 
(Broyles and Moss, 1986), which is also well conserved 
with the variola L6R open reading frame (Massung et al., 
1994). Thus, we found that the location and orientation 
of the two Leporipoxvirus phosphatase genes are closely 
correlated, and both contain significant similarities to the 
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FIG. 1. Genomic Iocalizations of the phosphatase open reading frames in myxoma virus and Shope fibroma virus (SFV). BamHI maps of myxoma 
(Russell and Robbins, 1989) and Shope fibroma (Delange et aL, 1984) viruses are shown, oriented in the same direction as has been standardized 
for vaccinia virus (Goebel et aL, 1990). The 6.4~kb myxoma BamHl-I fragment and the 2.7-kb SFV BamHFM fragment have been expanded. The 
entire SFV BamHI-M fragment has been sequenced (solid arrows), whereas portions of the myxoma BamHl-I fragment remain to be sequenced 
(dotted arrows). The phosphatsse open reading frames in myxoma and SFV are named I1L and M1 L, respectively. 12R and M2R have closely related 
homologues similarly positioned in the genomes of vaccinia and variola. (RP0147) indicates close similarity with the C-terminal portion of the largest 
vaccinia RNA polymerase subunit, RP0147. B, BamHI; TIR, terminal inverted repeat. 
genomic organization of the two Orthopoxvirus phospha- 
tase genes studied to date. 
Comparison of the poxviral phosphatase amino acid 
sequences 
Database searching demonstrated that the highest de- 
gree of homology at the amino acid level to myxoma IlL 
and SFV M1L was to the vaccinia H1L tyr/ser phospha- 
tase (Guan eta/., 1991a) and to the variola virus IlL 
phosphatase (Safronov etaL, 1993; Massung etaL, 1994). 
Alignment of these four poxviral phosphatases demon- 
strates the extent of this homology (Fig. 3). Spanning the 
entire length of the polypeptides, 62% of the amino acids 
were found to be identical in all four proteins. As well, 
only five amino acids differ between the SFV and myxoma 
proteins, while there are four amino acid differences be- 
tween the vaccinia and variola proteins. All four viral 
phosphatases contain the conserved signature se- 
quence motif (I/V)HCXAGXXR(SFF)G (Fischer etaL, 1991), 
characteristically located within the catalytic domain of 
tyrosine phosphatases. Within this motif is the active site 
cysteine, which is essential for tyrosine phosphatase 
function (Streuli et aL, 1989; Guan et aL, 1991a). When 
compared to phosphatases from Yersinia (Guan and 
Dixon, 1990), S. cerevisiae (Guan et aL, 1991b), and S. 
pombe (Gautier etaL, 1991), the highest degree of homol- 
ogy was found within the signature sequence motif (data 
not shown). Thus, the poxviral tyrosine phosphatases 
constitute proteins which are highly conserved, both 
within and between different genera. 
Myxoma I1L is expressed as a late gene product 
Poxviral promoters have been characterized as early, 
intermediate, and late (Vos and Stunnenberg, 1988; Davi- 
son and Moss, 1989a,b; Keck et aL, 1990), and the four 
poxviral phosphatases in Fig. 3 all contain the typical 
TAAAT motif characteristic of late poxvirus promoters 
(Davison and Moss, 1989b). The TAAAT motif of the myx- 
oma and SFV phosphatase genes overlaps with the puta- 
tive initiating ATG, also a typical feature of late promoters. 
Northern blot analysis was used to examine the expres- 
sion of the IlL gene in myxoma-infected ceils. As seen 
in Fig. 4, IlL transcripts are seen only at late times, 
following the commencement of viral DNA synthesis, pre- 
dominantly beginning 7 hr postinfection (lane 4). Also, 
the heterogeneous ize of the viral transcripts is another 
feature commonly observed for late poxviral mRNAs. 
When the same viral RNA samples were subjected to 
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CGCAAAAGCGGCTCCTACATCGGGAATCGGTTTCAAGTATATACTQAATC 
TTACGACTGAGAAAAAATACACAATTAAAAACTCATCTGTCACGATCATT 
I f l l l  II I l l  I I I l l  II I f l l l J l l  I l l  I l l l  I I I I I  
TTACGACTG... AAAAATACACGATCAAAAACTCGTCTATCACGATCATT 
CATATGCCGTTGGTAGACGACGAATACACAGATTTAACTAAATATTTTgA 
I l l l l  I l l l l l l l  I l l l l l l l  II I I I I  I I I I I I  I I I I I I  
CATATQCCGTTGGTAGATGACGAATATACGGATTTAACTAAQTATTTTGA 
TTACACTACCACGTTTCTATCCAATTQTGAGGATAAACATTATCCCGTAT 
II II I I I f l  I I I I I I I I l l  I l l l l  I I I I I l l l  I l l l l  
TTATGCCACTACGTTTCTATCCAATTGCGAGGACAAACATTATCCCGTAT 
TAGTCCACTGCATGQCCGGCGTTAATAGAAGCGGGGCTATAATTATGGCG 
r i l l  III I I I I  II II III I I I I I I I  I I I I I I I I  I I I I I  
TQGTCCACTGTATGGCCGGTGTAAATCGAAGCGGGGCTATAATTATGGCG 
TATCTTATGTCTAGAAAAAGTAAAGACATACCCGCATTTATGTACTTTTT 
I l l l l l l l l l l l l l  I l l  I I I I I I I I I I I I I  I l l l l l l  I I I I I  
TATCTTATQTCTAGAAAAAGCAAAGACATACCCGCGTTTATGTACTTTTT 
GTATATCTATCACTCCATACGAGAACAACGAGGAGCGTTTTTGGAAAATC 
I I I I I I I I I I l l l l  I I I I  I I I I I I I I I I I I  I I I I I I I I  I I I I I I  
GTATATCTATCACTCCATACGGGAACAACGAGGAGCQTTTTTGGAAAATC 
CGTCATTTAGACGACAAATTATAGAAAAATATATCATCAACGAAAC/~-'~ 
I I I I  II I I I I l l l l  I I I I I I l l l l l l l l l l l l l l l l l l l l l l l l l l l l  I 
CGTCGTTCAGACGACAGATTATAGAAAAATATATCATCAACGAAACAIT_.~ 
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RG. 2. Alignment of myxoma and SFV protein tyrosine phosphatase 
(PTPase) open reading frames. Sequence alignment of the myxoma 
IlL open reading frame (GenBank Accession No. L31960) with the SFV 
M1L open reading frame. Restriction enzyme digestions mapped the 
5' end of the myxoma IlL open reading frame approximately 2.2 kb 
from the left end of the myxoma BamHl-I fragment, as oriented in Fig. 
1. The SFV M1L open reading frame begins 424 nucleotides from the 
right end of the SFV BamHI-M fragment (GenBank Accession No. 
L32180) and ends 1744 nucleotides from the left end of the SFV BamHI- 
M fragment, as oriented in Fig. 1. The start and stop codons are boxed, 
while the putative late promoter element, TAAAT, is underlined. The 
filled arrow indicates the start of the phosphatase open reading frames, 
while the open arrow indicates the start of the myxoma 12R and SFV 
M2R open reading frames (refer to Fig. 1 ). Vertical lines depict identical 
nucleotides among the two sequences, and dots within the sequence 
denote gaps introduced for maximal alignment. 
Northern blot analysis with a probe to a control early 
gene, the myxoma T7 interferon-3, receptor homolog (Up- 
ton et al., 1992), single transcripts were observed only 
atthe 2- and 4-hr postinfection samples (data not shown). 
Thus, we conclude that he IlL gene of myxoma is ex- 
pressed as a classical late viral gene. 
Myxoma I lL protein is a functional dual specific 
tyrosine/serine phosphatase 
Given the similarity between the SFV and the myxoma 
phosphatases at the amino acid level (97% identity), all 
subsequent experiments were carried out with the myx- 
oma protein. To demonstrate that the myxoma I1L gene 
encodes a functional phosphatase, the protein was ex- 
pressed as a GST fusion protein, in parallel with the 
vaccinia H1L protein and a myxoma mutant (IlL-C11OS), 
VarPTP MDKKSLYKYL LLRSTGDMRR AKSPTIMTRV TNNVYLGNYK NAMNAPSSEV 50 
MyxPTP MDKKSLYENV LLKSTGALPK ARVPTKMMRV TDYVYLGNYN DAKAAPTSGI 50 
SFVPTP MDKKSLYENV LLKSTGALPK ARIPTKMMRV TDYVYLGNYN DAKAVPTSGV 50 
ooo  oeoo  leo  eooo  
W/PTP KFKYVLNLTM D,I~LP~N INIIHIPLVD ;TT~ISI~;DV~A~Z~K~ 99
VarPTP KFKYVLNLTM D. KYTLPNSN INIIHIPLVD DTTTDISKYF DDVTAFLBKC 99 
MyxPTPGFKYILNLTT E. KYTIKN$5 ITIIHMPLVD DEYTDLTKYF DYATTFLSNC 99 
SFVPI'PGFKYILNLTT EKKYTIKNBS VTIIHMPLVD DEYTDLTKYF DYTTTFLSNC I00 
VarPTP DQRNEPVLVHmVAGVNRSQA MILAYLNS. K NKESSPMLYF LYVYHSMRDL 148 
MyxPTP EDKHYPVLVHD'IAGVNRSGA IIMAYLMSRK SKDIPAFMYF LYIYHSIREQ lq9 
SFVPTP EDKHYPVLVHJm~IAGVNRSGA IIMAYLMSRK SKDIPAFMYF LYIYHSIREQ 150 
. . . . . . . . .  ~1;~i; 1 VVPTP RGAFVENPSF K V DKN 171 
VarPTP RGAFVENPSF KRQIIEKYVI DKN 171 
TPRGAFLENPSF RRQIIEKYII NET 172 
PRGAFLENPSF RRQIIEKYII NET 173 
FIG. 3. Alignment of poxviral phosphatases. Amino acid sequence 
comparison of phosphatases from vaccinia (WPTP, PIR GenBank Ac ~ 
cession No. A42514), variola (VarPTP, GenBank Accession No. X67119), 
myxoma (MyxPTP, GenBank Accession No. L31960), and SFV (SFVPTP, 
GenBank Accession No. L32180). Dots in the amino acid sequences 
denote gaps .introduced for maximal alignment. Conserved amino acid 
residues among all four viral polypeptides are indicated by filled circles. 
The tyrosine phosphatase catalytic signature sequence is underlined, 
with the essential cysteine residue highlighted. 
in which the putative active site cysteine was changed 
to a serine. This cysteine to serine mutation at amino 
acid 110 was previously shown to abolish all phospha- 
tase activity of vaccinia H 1 L (Guan et al., 1991a). As seen 
in Figs. 5A and 5B, both myxoma IlL and vaccinia H1L 
are capable of hydrolyzing p-nitrophenyl phosphate, a 
chromogenic substrate structurally related to phospho- 
tyrosine, and dephosphorylating tyrosine-phosphorylated 
myelin basic protein, respectively. Loss of the active site 
cysteine in I1 L-C110S completely abolished the ability of 
the mutant myxoma I1 L enzyme to dephosphorylate both 
substrates. 
Most tyrosine phosphatases possess strict specificity 
kb 
1 2 3 4 5 
FIG. 4. Northern blotting analysis of RNA extracted from myxoma- 
infected cells, using myxoma I1L probe. RNA from mock-infected cells 
(lane 1) and myxoma virus-infected cells at 2, 4, 7, and 10 hr postinfec- 
tion (lanes 2-5, respectively) were extracted, size fractionated, blotted, 
and hybridized with a PCR-amplified myxoma IlL probe. Position of 
RNA size standards are shown at the left. 
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FIG. 5. Substrate specificities of the viral phosphatases. (A) Hydrolysis of the cfiromogenic substrate p-nitrophenyl phosphate (pNPP). (B) Dephos- 
phorylation of tyrosine-phosphorylated myelin basic protein (MBP). (C) Dephosphorylation of serine phosphorylated casein. (D) Dephosphorylation 
of serine phosphorylated MBP. Hydrolysis of pNPP was performed by incubating increasing amounts of purified viral enzyme with 10 mM pNPP 
for 30 min at 30 °. Sodium carbonate was used to stop the reaction, and substrate cleavage measured by the increase in absorbance at 410 nm. 
Tyrosine-phosphorylated MBP (1 X 104 cpm) and serine phosphorylated casein and MBP (1 x 105 cpm each) were incubated with increasing 
amounts of purified viral enzyme and incubated at 30 ° (tyr-MBP) or at room temperature (ser-casein and ser-MBP) for 30 min. Reactions were 
stopped with the addition of acidic charcoal which was subsequently pelleted, and the supernatants then quantitated for ~2p release by Cerenkov 
counting. Assays were performed in triplicate, and in all cases, the enzymes used are expressed GST-fusion proteins which were purified by 
glutathione-Sepharose chromatography. B, Myxoma I1 L; A, myxoma I1L mutant (0110S); e, vaccinia H1L. 
for tyrosyl-phosphorylated residues (Charbonneau and 
Tonks, 1992). However, the vaccinia phosphatase H1L 
was shown to possess specificity for phosphoserine as 
well as phosphotyrosine (Guan et al., 1991a). Given the 
substantial differences between the biological character- 
istics of vaccinia and myxoma, it was important o deter- 
mine if myxoma I1L also possessed dual substrate speci- 
ficity. As shown in Figs. 50 and D, the vaccinia and 
myxoma phosphatases each dephosphorylated phos- 
phoserine residues on both casein and myelin basic pro- 
tein substrates. Once again, mutation of the active site 
cysteine 110 to serine in myxoma I1L totally abolished its 
enzymatic activity. Neither the vaccinia nor the myxoma 
enzyme was capable of dephosphorylating serine-phos- 
phorylated phosphorylase A (data not shown). Although 
myxoma I1L appears to have a higher specific activity 
for the dephosphorylation of tyrosine-phosphorylated 
substrates than does vaccinia H1 L, and the~two enzymes 
apparently have the opposite affinities for serine-phos- 
phorylated substrates (Fig. 5), it must be noted that both 
enzymes are GST fusion proteins expressed from a bac- 
terial system, and the substrates used for these assays 
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I~111 I~111 
[~--p11-~ j 
\ 3,,. / 
rnyxoma I lL  ,~  \ i /  TAA 
Xh~'~, i '~"  ~ ....... ~1~-~mH l 
e 
Selection Plaques % Recombinant % Parental blue/white Genomes detected 
Virus Virus in blue plaques 
Round Screened (blue) (white) ratio ; wildtype mutant 
1 2870 0.2 99.8 1:500 4" 4- 
2 429 1.9 98.1 1:52 4" 4- 
3 375 2.1 97.9 1:47 4" 4" 
4 188 2,1 97.9 1:47 4" 4" 
5 307 7.5 92.5 1:12 4" 4" 
Re. 6. The myxoma IlL phosphatase gene is essential for virus 
viability. (A) Construction of one of the disruption vectors designed to 
inactivate he myxoma phosphatase gene by homologous recombina- 
tion. A 3.15-kb pl 1-LacZ Bglll cassette was inserted into the myxoma 
I1L open reading frame, replacing 178 nucleotides of coding sequence. 
151 and 190 nucleotides of IlL coding sequences remained intact at 
the 5' and 3' ends, respectively. The entire phosphatase/p11-LacZ 
fusion was cloned into the Xhol and BamHI sites of the multiple cloning 
site {mcs) of Bluescript SK + to generate pl 1L-LacZb, used for the experi- 
ments in B. The opposite orientation of pl 1-LacZ (pll L-LacZa) was also 
constructed (not shown) and found to give identical results. (B) Absence 
of viability of an IlL phosphatase disruption mutant myxoma virus. 
Myxoma virus-infected cells were transfected with the disruption vector 
pllL-LacZb. Due to the presence of the LacZ gene, cells harboring 
recombinant virus stain blue upon the addition of X-gal to an agarose 
overlay. The percentage of recombinant virus versus parental virus was 
scored by counting blue versus white plaques over five successive 
selection rounds in which individual blue plaques were picked and 
replated in the presence of X-gal. Representative plaques were chosen 
in each selection round and analyzed for the presence (+) of wild type 
IlL alleles and IlL-disrupted alleles by PCR analysis, as described 
under Materials and Methods. 
are useful only as in vitro targets. Thus, the biological 
preferences of these two viral phosphatases for physio- 
logically relevant phosphorylated substrates remains to 
be determined. 
Myxoma I l L  is an essential gene 
In order to characterize the requirement for the myx- 
oma dual specific phosphatase in vivo, we attempted to 
construct a mutant virus containing a disrupted I1L open 
reading frame by homologous recombination. An I1L dis- 
ruption plasmid vector was constructed by replacing 178 
nucleotides of myxoma I1L coding sequences with a 
3.15-kb Bglll p11-LacZ cassette (Fig. 6A). Both orienta- 
tions of p11-LacZ were constructed and tested for the 
ability to generate phosphatase-minus viruses, but were 
found to give identical results (data not shown). Recombi- 
nant viruses were selected for by plating under agarose 
containing X-gal, which would cause plaques from re- 
combinant viruses that express fl-galactosidase to stain 
blue. Five rounds of plaque purification continued to gen- 
erate blue plaques that contained mixtures of wild type 
and mutant myxoma viruses but failed to produce virus 
isolates possessing only the disrupted copy of I1 L (Fig. 
6B). All blue virus plaques at each round tested were 
strictly heterogeneous in nature, containing variable ra- 
tios of viruses possessing the wild-type allele to those 
containing the disrupted phosphatase gene. We con- 
clude that since viruses containing the disrupted I lL  
gene could not propagate without the presence of a wild- 
type complementing gene product, then the myxoma 
phosphatase protein must be required for viral propaga- 
tion. In blue plaques harboring both the mutant and the 
wild-type viruses, sufficient wild-type phosphatase must 
therefore be present in doubly infected cells to permit 
propagation of the mutant phosphatase disruption virus 
and thus maintain the appearance of blue plaques. To 
confirm these findings, PCR analysis was routinely uti- 
lized, using myxoma I1L primers and primers specific for 
the LacZ gene, to demonstrate that individual blue 
plaques which contained copies of virus genomes bear- 
ing the disrupted phosphatase gene also always har- 
bored wild-type parental virus with the full-length phos- 
phatase gene (Fig. 6B). Thus we conclude that expres- 
sion of I lL  must be essential for viral propagation in 
tissue culture. 
DISCUSSION 
Protein tyrosine phosphatases are now recognized as 
important regulatory enzymes, which in concert with pro- 
tein tyrosine kinases regulate protein phosphorylation 
within a cell. Tyrosine phosphatases, whether receptor- 
like or soluble, generally possess a common catalytic 
domain, where the active site cysteine is located within 
the signature sequence motif (V/I)HCXAGXXR(S/T)G (Fi- 
scher et aL, 1991). Here, we have characterized the tyro- 
sine phosphatases encoded by the Leporipoxviruses 
Shope fibroma virus (SFV) and myxoma virus, which both 
contain the characteristic signature sequence motif, and 
which, at least in the case of myxoma, appears to be 
essential for virus viability. We have also characterized 
the specificity of the myxoma enzyme in vitro. 
The poxviral phosphatases belong to a relatively new 
subfamily of soluble tyrosine phosphatases which, aside 
from the signature sequence motif, contain little similarity 
to other soluble tyrosine phosphatases. The phospha- 
tases encoded by poxviruses are much smaller than 
other characterized cellular tyrosine phosphatases, 
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which typically contain catalytic domains larger than the 
entire viral phosphatase proteins. Aside from the con- 
served tyrosine phosphatase signature sequence motif, 
the poxviral phosphatases do not contain any of the di- 
verse protein sequenpes which appear to localize intra- 
cellular tyrosine phosphatases to defined subcellular 
compartments (Mauro and Dixon, 1994). Also, while most 
of the nonviral tyrosine phosphatases have been charac- 
terized as maintaining strict specificity for phosphotyro- 
syl residues, the poxviral enzymes have the ability of 
dephosphorylating both phosphotyrosyl and phospho- 
seryl residues in vitro. 
Phosphatases encoded by poxviruses, including the 
myxoma ItL protein, are extremely intriguing when con- 
sidering their potential biological functions. While the 
myxoma I1L phosphatase is characterized as a member 
of the tyrosine phosphatase family due to the presence 
of the characteristic signature sequence motif, we have 
shown it to possess dual specificity in vitro to both phos- 
photyrosyl and phosphoseryl residues, similar to that of 
the vaccinia H1L phosphatase (Guan et aL, 1991a). Ser- 
ine/threonine phosphatases generally exhibit broad and 
overlapping substrate specificities and are known to 
function in glycogen and hepatic metabolism, protein 
synthesis, oocyte maturation, and muscle contractility 
(reviewed in Cohen, 1989). Tyrosine phosphatases, on 
the other hand, have been implicated in signal transduc- 
tion, tumor suppression, cellular proliferation, and differ- 
entiation control (reviewed in Lau and Baylink, 1993). 
Dual specific phosphatases, depending on their promis- 
cuity, could thus potentially function in a wide variety of 
capacities. 
In this report, we demonstrate for the first time the 
definitive importance of the poxviral phosphatases by 
showing that myxoma I1L is essential to virus viability in 
tissue culture. The inability to segregate myxoma virus 
isolates containing a disrupted copy of the I1L open read- 
ing frame from wild-type helper virus indicates that the 
myxoma phosphatase plays a crucial role in the viral life 
cycle. With respect to the poxviral life cycle, a virus- 
encoded phosphatase such as myxoma IlL could func- 
tion in viral processes obligatory for replication and prop- 
agation, in nonessential events that govern virulence, 
host-range, etc., or possibly in both classes of activities. 
In general, viral open reading frames which encode pro- 
teins that function to catalyze essential features of viral 
replication are clustered at central regions of the ge- 
nome, are conserved among poxviruses, and are essen- 
tial for basic virus survival (Turner and Moyer, 1990; 
Buller and Palumbo, 1991). Virus genes critical for patho- 
genesis and host-virus interactions, however, typically 
map toward the termini of the genome, show a high 
degree of variability among poxviruses, and are nones- 
sential for viral replication in tissue culture (Traktman, 
1990). The open reading frames which encode for all 
the known poxviral phosphatases are located within the 
central portion of the virus genome, adjacent to another 
essential virus gene, rpo147. Homologous phosphatase 
genes have also been reported in the central regions of 
eight other Orthopoxviruses, and a related gene has also 
been detected in the baculovirus Autographa californ/ca 
(Hakes et aL, 1993). We believe that due to the high 
degree of similarity in both genomic localization and ori- 
entation, and in amino acid sequence, the other poxviral 
phosphatases are also essential enzymes. In addition, 
the vaccinia H1L phosphatase has recently been re- 
ported to be packaged into virions and required for early 
virus gene expression in vivo (K. Liu, Lemon, and P. Trakt- 
man, personal communication), further attesting to the 
essentiality of this gene family for virus viability. 
However, it is entirely possible that the myxoma phos- 
phatase also functions directly in the progression of myx- 
omatosis in rabbits; and that other poxviral phosphatases 
function in pathogenesis as well. The YOP2b phospha- 
tase, which is expressed from the yopH gene in three 
different species of the Yersinia genus, has been shown 
to be essential for the virulence of this pathogen (Guan 
and Dixon, 1990). YOP2b functions by dephosphorylating 
at least three major host proteins, whose roles in patho- 
genesis remain to be determined (Bliska et al., 1991). 
Since Yersinia and poxvirus infections each radically af- 
fect the host ceil macromolecular synthesis, it is feasible 
to postulate that the essential YOP2b and myxoma phos- 
phatase proteins are key players in modulating host- 
protein phosphorylation. Furthermore, cdc25, which is a 
dual-specificity tyrosine phosphatase structurally related 
to the poxviral phosphatases, is known to perform a criti- 
cal regulatory function in the yeast cell cycle (Dunphy 
and Kumagai, 1991; Gautier et aL, 1991). The S. pombe 
cdc25 protein functions to activate the protein kinase 
p34 °do2 by dephosphorylating Tyr15 in the ATP-binding 
site and ultimately drives the cell into mitosis. Poxviruses 
are known to be relatively S-phase independent and to 
replicate in both quiescent and proliferating host cells, 
and hence there would be a selective advantage to the 
virus specifically modulating the cell cycle machinery of 
the infected cell in situations of host cell quiescence. 
Recently, the crystal structure of human PTP1B was 
solved, allowing specific predictions to be made on how 
tyrosine phosphatases interact with target substrates 
(Barford et aL, 1994). The catalytic site of PTP1B was 
found to be located within a crevice, the base of which 
comprises the signature catalytic sequence motif con- 
taining the active site cysteine. Tyrosine side chains eas- 
ily fit into the crevice, allowing contact between the phos- 
phate moiety and the catalytic .cysteine at the crevice 
base, whereas serine and threonine side chains are pre- 
dicted to be too small to reach the base of the crevice, 
thus disallowing dephosphorylation of phosphoseryl and 
phosphothreonyl residues. While this observation pro- 
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duces a rationale for the strict phosphotyrosyl specificity 
of most cellular tyrosine phosphatases, it does not ex- 
plain how the dual-specific poxviral phosphatases func- 
tion. It has been shown for myxoma I1L (this paper) and 
vaccinia H1L (Guap et aL, 1991a), using mutants in the 
active site cysteine, that this residue is required for de- 
phosphorylation of both phosphotyrosyl and phospho- 
seryl residues. We predict that even though the dual- 
specificity poxvirus phosphatases contain the conserved 
tyrosine catalytic motif, the three-dimensional structures 
of the viral enzymes may have diverged Sufficiently from 
the larger cellular enzymes to allow a greater range of 
access by phosphorylated substrates. 
Many critical questions remain as to which biological 
substrates the poxviral phosphatases recognize (Tonks, 
1991). Given the essentiality of the myxoma I1L phospha- 
tase for virus viability, it seems likely that some of the 
phosphoprotein substrates are of virus origin. The possi- 
bility that cellular substrates, particularly those such as 
cell cycle regulators or phosphorylated intermediates 
that transduce signals from anti-viral cytokines such as 
TNF or interferon, are targets is particularly intriguing 
and merits further investigation. 
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